# A Study in Healthy Volunteers to Compare the Profiles of DA-3880 and EU Sourced ARANESP® (Amgen)

> **NCT02241200** · PHASE1 · COMPLETED · sponsor: **Dong-A ST Co., Ltd.** · enrollment: 64 (actual)

## Conditions studied

- Symptomatic Anemia

## Interventions

- **DRUG:** DA3880
- **DRUG:** Aranesp

## Key facts

- **NCT ID:** NCT02241200
- **Lead sponsor:** Dong-A ST Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08-18
- **Primary completion:** 2014-11-29
- **Final completion:** 2014-11-29
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2021-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02241200

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02241200, "A Study in Healthy Volunteers to Compare the Profiles of DA-3880 and EU Sourced ARANESP® (Amgen)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02241200. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*